“…Cancer is highly prevalent in the elderly, and cardiac toxicity of antineoplastic agents is currently a topic of major interest. Badescu et al have shown that some commonly used oncological treatments have adverse effects on coronary arteries, as they induce endothelial dysfunction, coronary artery spasm, thrombosis, and fibrosis [ 6 ]. These harmful structural and functional changes lead to cardiovascular events that require reduction or temporary or permanent stop of antineoplastic therapy, and all of these events have a negative impact on cancer outcomes.…”